Edition:
United States

Viveve Medical Inc (VIVE.OQ)

VIVE.OQ on NASDAQ Stock Exchange Capital Market

4.47USD
12:33pm EST
Change (% chg)

$0.18 (+4.20%)
Prev Close
$4.29
Open
$4.40
Day's High
$4.55
Day's Low
$4.40
Volume
45,502
Avg. Vol
55,308
52-wk High
$11.16
52-wk Low
$3.30

Latest Key Developments (Source: Significant Developments)

Viveve Announces Pricing Of Public Offering Of Shares
Thursday, 8 Feb 2018 08:01am EST 

Feb 8 (Reuters) - Viveve Medical Inc ::VIVEVE ANNOUNCES PRICING OF PUBLIC OFFERING OF SHARES OF COMMON STOCK.VIVEVE MEDICAL INC - PRICING OF AN UNDERWRITTEN PUBLIC OFFERING OF 10 MILLION SHARES OF ITS COMMON STOCK AT A PUBLIC OFFERING PRICE OF $3.00 PER SHARE.  Full Article

Viveve Announces Proposed Public Offering Of Shares Of Common Stock
Wednesday, 7 Feb 2018 04:01pm EST 

Feb 7 (Reuters) - Viveve Medical Inc ::VIVEVE ANNOUNCES PROPOSED PUBLIC OFFERING OF SHARES OF COMMON STOCK.VIVEVE MEDICAL - INTENDS TO USE NET PROCEEDS FROM OFFERING FOR SUPPORTING COMMERCIALIZATION OF ITS PRODUCTS, CLINICAL RESEARCH AND DEVELOPMENT.  Full Article

Viveve Announces Preliminary 2017 Fourth Quarter Results
Thursday, 4 Jan 2018 08:28am EST 

Jan 4 (Reuters) - Viveve Medical Inc ::VIVEVE ANNOUNCES PRELIMINARY 2017 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS AND PROVIDES 2018 REVENUE GUIDANCE.SEES FY 2018 REVENUE $22 MILLION TO $24 MILLION.SEES FY 2017 REVENUE $15.3 MILLION.FY2017 REVENUE VIEW $15.5 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 REVENUE VIEW $23.6 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Viveve Medical Inc files for mixed shelf of up to $50 million
Wednesday, 8 Nov 2017 05:17pm EST 

Nov 8 (Reuters) - Viveve Medical Inc :Viveve Medical Inc files for mixed shelf of up to $50 million .  Full Article

Viveve reports Q3 loss per share $0.50
Wednesday, 8 Nov 2017 04:02pm EST 

Nov 8 (Reuters) - Viveve Medical Inc :Viveve announces third quarter 2017 financial results.Q3 loss per share $0.50.Q3 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S.Q3 revenue $4.1 million versus i/b/e/s view $3.7 million.  Full Article

Viveve releases preliminary Q3 2017 financial results
Wednesday, 18 Oct 2017 08:28am EDT 

Oct 18 (Reuters) - Viveve Medical Inc :Viveve releases preliminary third quarter 2017 financial results.Viveve Medical- sees Q3 revenue from sale of 60 Viveve systems, about 2,700 disposable treatment tips, ancillary consumables to be about $4.1 million​‍​.  Full Article

Viveve gets regulatory nod to market Viveve System in Mexico
Tuesday, 17 Oct 2017 08:28am EDT 

Oct 17 (Reuters) - Viveve Medical Inc :Viveve announces regulatory approval for Viveve System in Mexico.Viveve Medical - received approval from Mexican regulatory authority, COFEPRIS, to market Viveve System in Mexico for treatment of vaginal introitus​.Viveve Medical Inc - working to submit IDE to FDA to conduct pivotal study on use of Viveve System for improvement in sexual function in women​.  Full Article

Viveve announces regulatory approval for Viveve System in Taiwan
Tuesday, 10 Oct 2017 08:28am EDT 

Oct 10 (Reuters) - Viveve Medical Inc :Viveve announces regulatory approval for Viveve System in Taiwan.Viveve Medical - got approval to market Viveve System from Taiwanese FDA for use in general surgical procedures for electrocoagulation,hemostasis​.Viveve - In process of submitting investigational device exemption to U.S FDA to conduct study on use of device for improvement in sexual function in women​.  Full Article

Viveve announces additional regulatory approvals in Middle East
Tuesday, 12 Sep 2017 08:28am EDT 

Sept 12 (Reuters) - Viveve Medical Inc :Viveve announces additional regulatory approvals in Middle East.Viveve Medical Inc - ‍has received regulatory approvals for Viveve system in Bahrain, Kuwait, and Qatar​.  Full Article

Viveve Medical reports Q2 loss per share $0.54
Thursday, 10 Aug 2017 04:01pm EDT 

Aug 10 (Reuters) - Viveve Medical Inc -:Viveve announces second quarter 2017 financial results and strategic partnership with Incontrol Medical, Llc.Q2 loss per share $0.54.Q2 earnings per share view $-0.43 -- Thomson Reuters I/B/E/S.Q2 revenue $3.1 million versus i/b/e/s view $3.2 million.Viveve Medical Inc - entered into an exclusive distribution agreement and strategic investment with Incontrol Medical, Llc.Viveve Medical Inc - exclusive distribution agreement to treat various incontinence conditions and strengthen pelvic floor muscles.  Full Article

BRIEF-Viveve Announces Pricing Of Public Offering Of Shares

* VIVEVE ANNOUNCES PRICING OF PUBLIC OFFERING OF SHARES OF COMMON STOCK